Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
Colorcon
Baxter
US Department of Justice
Argus Health
Johnson and Johnson
QuintilesIMS
Express Scripts

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020746

« Back to Dashboard

NDA 020746 describes RHINOCORT ALLERGY, which is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the RHINOCORT ALLERGY profile page.

The generic ingredient in RHINOCORT ALLERGY is budesonide. There are twenty-one drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Summary for 020746
Tradename:RHINOCORT ALLERGY
Applicant:Astrazeneca Pharms
Ingredient:budesonide
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020746
Suppliers and Packaging for NDA: 020746
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RHINOCORT ALLERGY budesonide SPRAY, METERED;NASAL 020746 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-510 50580-510-01 1 BOTTLE in 1 CARTON (50580-510-01) > 60 SPRAY, METERED in 1 BOTTLE
RHINOCORT ALLERGY budesonide SPRAY, METERED;NASAL 020746 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-646 50580-646-01 1 BOTTLE in 1 CARTON (50580-646-01) > 60 SPRAY, METERED in 1 BOTTLE

Profile for product number 003

Active Rx/OTC/Discontinued:OTCDosage:SPRAY, METERED;NASALStrength0.032MG/SPRAY
Approval Date:Mar 23, 2015TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Express Scripts
UBS
Harvard Business School
Deloitte
Johnson and Johnson
Healthtrust
Federal Trade Commission
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.